Novel approaches to assessing cardiac safety--proceedings of a workshop: regulators, industry and academia discuss the future of in silico cardiac modelling to predict the proarrhythmic safety of drugs

Drug Saf. 2011 May 1;34(5):439-43. doi: 10.2165/11591950-000000000-00000.
No abstract available

Publication types

  • Congress
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arrhythmias, Cardiac / chemically induced*
  • Computer Simulation*
  • Drug Design
  • Drug-Related Side Effects and Adverse Reactions*
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels / antagonists & inhibitors
  • Forecasting
  • Humans
  • Long QT Syndrome / chemically induced

Substances

  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels